首页> 外国专利> Analysis of the anti-coagulated whole blood sample still

Analysis of the anti-coagulated whole blood sample still

机译:抗凝全血标本的分析

摘要

(57) form component in the [summary] anticoagulated whole blood sample is still, in a chamber that has a thickness through surface for variation due to (4,8) wall converging opposing sample chamber (14) are analyzed visually or optically. At least one of the converging walls of the chamber are transparent blood sample components to be observed. Varying thickness of the chamber, creating a region of small thickness of the first where the stationary monolayer of red blood cells in the sample will be present in an after filling it sample is introduced into the chamber. Forms large components such as white blood cells in the sample can not enter the region of the small thickness of the chamber. Red blood cells that are present in (B, C) of the region of greater thickness will be aggregated so as to form a small cavity and continuous Zenigata. It can be measured in the field when the sample is analyzed, or may be predetermined exact thickness of the chamber at any particular position in the chamber. By mixing with a blood sample a certain dye, various other information and characteristics, by measuring the signal and other various colors emitted from the sample in (1,3,5) different locations in the chamber by (54), or may be by visual inspection of the sample in the chamber, it is derived from various forms of components in the sample scanning device capable of. The thickness of the small area of ​​the sample can be calculated by the instrument as a function of radiation intensity signal from the dye or stain. It is possible and may be radiation is the result of sample fluorescence, or results of signal strength through the sample. Particle volume can be measured as a function of the firing signal suppression caused by the particles. I can be derived from a blood sample placed in the sample chamber erythrocyte sedimentation speed (ESR).
机译:(57)抗凝全血样品的组成成分仍然静止,在腔室中,该腔室具有由于(4,8)壁会聚而相对的样品室(14)而变化的贯穿表面的厚度,用于目视或光学分析。腔室的会聚壁中的至少一个是要观察的透明血液样本成分。改变腔室的厚度,在第一个区域中创建一个较小的厚度区域,在该区域中,将样品填充后将在样品中存在稳定的单层红细胞。形成较大成分的样品如白细胞不能进入小腔室的区域。存在于较厚区域的(B,C)中的红细胞将聚集在一起,从而形成一个小腔和连续的Zenigata。可以在分析样品时在现场进行测量,也可以在腔室内任何特定位置预先确定腔的精确厚度。通过与某种血液样本混合某种染料,各种其他信息和特征,通过在腔室中不同位置的(1、3、5)处测量从该样本发出的信号和其他各种颜色,可以是(54),也可以是目视检查室中的样品,它衍生自能够在样品扫描装置中使用的各种形式的组件。样品小面积的厚度可以由仪器根据染料或色斑的辐射强度信号来计算。辐射是可能的,也可能是样品荧光的结果,或者是穿过样品的信号强度的结果。可以根据由颗粒引起的发射信号抑制来测量颗粒体积。我可以从放置在样本室中的血液样本中获得红细胞沉降速度(ESR)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号